EOLS Evolus, Inc.
Healthcare$6.09-5.58%ClosedMarket Cap: $401.1M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
-13.79
P/S
1.33
EV/EBITDA
-36.78
DCF Value
$8.26
FCF Yield
-10.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
65.5%
Operating Margin
-9.6%
Net Margin
-14.4%
ROE
174.9%
ROA
-19.7%
ROIC
-18.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $73.1M | 64.8% | $-6.9M | $-10.7M | $— | — |
| Q4 null | $90.3M | 65.7% | $-291.0K | $130.0K | $— | — |
| FY null | $297.2M | 64.9% | $-37.6M | $-51.6M | $— | — |
| Q3 null | $69.0M | 66.5% | $-11.5M | $-15.7M | $— | — |
| Q2 null | $69.4M | 65.3% | $-10.2M | $-17.1M | $— | — |
| Q1 null | $68.5M | 68.1% | $-15.2M | $-18.9M | $— | — |
| Q4 null | $78.9M | 63.8% | $-2.3M | $-6.8M | $— | — |
| FY null | $266.3M | 68.5% | $-34.4M | $-50.4M | $— | — |
| Q3 null | $61.1M | 70.2% | $-15.5M | $-19.2M | $— | — |
| Q2 null | $66.9M | 70.3% | $-7.7M | $-11.3M | $— | — |
| Q1 null | $59.3M | 68.3% | $-8.9M | $-13.1M | $— | — |
| Q4 2023 | $61.0M | 63.6% | $-8.6M | $-11.8M | $-0.21 | — |